MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome

Magnetic Resonance in Medicine

Volumn 41, Issue 1, 1999, Pages 156-162

  Hauger, Olivier ^a   Delalande, Christophe ^a   Trillaud, Hervé ^a   Deminiere, Colette ^c   Quesson, Bruno ^a   Kahn, Haleem ^c   Cambar, Jean ^b   Combe, Christian ^d   Grenier, Nicolas ^a  

^a CNRS University Bordeaux Segalen   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

^d HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Contrast media; Kidney; Macrophage; Magnetic resonance imaging

Indexed keywords

CONTRAST MEDIA; CYTOLOGY; MACROPHAGES; MAGNETIC RESONANCE IMAGING; RATS;

EXPERIMENTAL MODELING; INTRAVENOUS INJECTIONS; IRON OXIDE PARTICLES; KIDNEY; MACROPHAGE INFILTRATIONS; NEPHROTIC SYNDROME; SIGNAL INTENSITIES; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

IRON OXIDES;

PUROMYCIN AMINONUCLEOSIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MALE; NEPHROTIC SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

EID: 0032945108     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2594(199901)41:1<156::AID-MRM22>3.0.CO;2-C     Document Type: Article

References (24)

1. Main IW, Nikolic-Paterson DJ, Atkins RC. T cells and macrophages and their role in renal injury. Semin Nephrol 1992; 12:428-440.
2. Van Goor H, Ding G, Fees-Folts D, Grond J, Schreiner GF, Diamond JR. Macrophages and renal disease. Lab Invest 1994; 71:456-464.
3. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int 1995; 48:753-760.
4. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady T, Ferruci JT Jr. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 1987; 162:211-216.
5. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
6. Benderbous S, Bonnemain B. Superparamagnetic nanoparticles as blood pool contrast agents: contribution to pre-clinical investigations. Der Radiologe 1995; 35:248-252.
7. Majumdar S, Zoghbi SS, Gore J. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat. Invest Radiol 1990; 25:771-777.
8. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR 1989; 152:167-173.
9. Weissleder R, Elizondo G, Wittenberg J. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
10. Vassalo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphography. Usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994; 193:501-506.
11. Tanoura T, Bernas M, Darkazanh A, Elam E, Unger E, Witte MH, Green A. MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis. AJR 1992; 159:875-881.
12. Trillaud H, Degrèze P, Combe C, Palussière J, Chambon C, Grenier N. Evaluation of intrarenal distribution of ultrasmall superparamagnetic iron oxide particles by magnetic resonance imaging and modification by furosemide and water restriction. Invest Radiol 1994; 29:540-546.
13. Frenk S, Antonowitz I, Craig JM, Metcoff J. Experimental nephrotic syndrome induced in rats by aminonucleoside. Renal lesions and body electrolyte composition. Proc Soc Exp Biol Med 1995; 89:424-427.
14. Ryan GB, Karnovsky MJ. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 1975; 8:219-232.
15. Caulfield JP, Reid JJ, Farquhar MG. Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Lab Invest 1976; 34:43-59.
16. Farquhar MG, Wissing SL, Palade GE. Glomerular permeability. I. Ferritin across the normal glomerular capillary wall. J Exp Med 1961; 113:47-65.
17. Kanwar YS, Rosenzweig LJ. Altered glomerular permeability as a result of focal detachment of visceral epithelium. Kidney Int 1982; 21:565-574.
18. Diamond JR, Pesek-Diamond I. Sublethal λ-irradiation during acute puromycin nephrosis prevents late renal injury; role of glomerular and interstitial macrophages. Am J Physiol 1991; 260:779-786.
19. Harris KGP, Lefkowith JB, Klahr S, Schreiner GF. Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest 1990; 86:1115-1123.
20. Eddy AA, Michael AF. Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 1988; 33:14-23.
21. Diamond JR, Pesek I, McCarter MD, Karnovsky MJ. Altered functional characteristics of rat macrophages during nephrosis. Am J Pathol 1989; 135:711-718.
22. Chambon C, Clement O, LeBlanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11:509-519.
23. Rozenman Y, Zou X, Kantor HL. Signal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images: the role of diffusion. Magn Reson Med 1990; 14:31-39.
24. Ding S, Trillaud H, Yongbi M, Rolett E, Weaver JB, Dunn JF. High resolution renal diffusion imaging using a fast steady-state free precession sequence. Magn Reson Med 1995; 34:586-595.